IVC treatment between primary and second TURBT may improve the prognosis of high-risk NMIBC patients receiving BCG treatment

IVC treatment between primary and second TURBT may improve the prognosis of high-risk NMIBC patients receiving BCG treatment

Abstract To explore whether intravesical chemotherapy (IVC) between primary and second transurethral resection of bladder tumor (TURBT) affects the prognosis of non-muscle invasive bladder cancer (NMIBC) patients receiving Bacillus Calmette-Guérin (BCG) treatment. NMIBC patients who underwent a seco...

Full description

Bibliographic Details
Main Authors: Zhen Li, Zewei Wang, Yang Liu, Lei Yang, Ling Gu, Hailong Li, Wei Wang
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Scientific Reports
Subjects:
Non–muscle-invasive bladder cancer
Re-TURBT
BCG
Chemotherapy
Progression
Online Access:https://doi.org/10.1038/s41598-025-89008-x

Internet

https://doi.org/10.1038/s41598-025-89008-x

Similar Items